Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome

References

• NeufeldEMuenzerJThe mucopolysaccharidosesScriverCBeaudetASlyWValleDThe Metabolic and Molecular Bases of Inherited DiseaseNew York, NYMcGraw-Hill200134213452
   Google Scholar
• TomatsuSMontañoAMOikawaHImpairment of body growth in mucopolysaccharidosesPreedyVRHandbook of Growth and Growth Monitoring in Health and Disease 1New YorkSpringer201220912117
   Google Scholar
• PatelPSuzukiYMaedaMGrowth charts for patients with Hunter syndromeMol Genet Metab Rep2014151824955330
   PubMedGoogle Scholar
• TomatsuSMontañoAMOikawaHMucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatmentCurr Pharm Biotechnol201112693194521506915
   PubMed Web of Science ®Google Scholar
• RodriguezMMillerTLMackenzieWGDitroCChidekelASShafferTHCharacteristics of impulse oscillometry and thoracoabdominal motion in children with thoracic cage disordersPediatr Pulmonol201045767968620575094
   PubMed Web of Science ®Google Scholar
• TherouxMCNerkerTDitroCMackenzieWGAnesthetic care and perioperative complications of children with Morquio syndromePaediatr Anaesth201222990190722738181
   PubMed Web of Science ®Google Scholar
• KakkisEDMuenzerJTillerGEEnzyme-replacement therapy in mucopolysaccharidosis IN Engl J Med2001344318218811172140
   PubMed Web of Science ®Google Scholar
• MuenzerJWraithJEBeckMA phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)Genet Med2006846547316912578
   PubMed Web of Science ®Google Scholar
• MontañoAMTomatsuSGottesmanGSSmithMOriiTInternational Morquio A Registry: clinical manifestation and natural course of Morquio A diseaseJ Inherit Metab Dis200730216517417347914
   PubMed Web of Science ®Google Scholar
• TomatsuSMackenzieWGTherouxMCCurrent and emerging treatments and surgical interventions for Morquio A syndrome: a reviewRes Rep Endocr Disord20122657724839594
   PubMedGoogle Scholar
• HendrikszCJAl-JawadMBergerKIClinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVAJ Inherit Metab Dis201236230932222358740
   PubMed Web of Science ®Google Scholar
• BeckMGlösslJGrubisicASprangerJHeterogeneity of Morquio diseaseClin Genet19862943253313087664
   PubMed Web of Science ®Google Scholar
• OriiTKimanTSukegawaKLate onset N-acetylgalactosamine-6-sulfate sulfatase deficiency in two brothersConnect Tissue Res1981133169175
   Google Scholar
• FukudaSTomatsuSMasueMMucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild casesJ Clin Invest1992903104910531522213
   PubMed Web of Science ®Google Scholar
• OriiTMinamiRChibaTStudy on Morquio syndromeBone Metab1971517278
   Google Scholar
• YasudaEFushimiKSuzukiYPathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorderMol Genet Metab2013109330131123683769
   PubMed Web of Science ®Google Scholar
• ShimadaTTomatsuSYasudaEChondroitin 6-sulfate as a novel biomarker for mucopolysaccharidosis IVA and VIIJIMD Rep201416152424850234
   PubMedGoogle Scholar
• MuenzerJLamsaJCGarciaADacostaJGarciaJTrecoDAEnzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary reportActa Paediatr Suppl200291439989912572850
   PubMedGoogle Scholar
• HendrikszCJBurtonBFlemingTRSTRIVE InvestigatorsEfficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled studyJ Inherit Metab Dis201437697999024810369
   PubMed Web of Science ®Google Scholar
• HarmatzPWhitleyCBWaberLEnzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)J Pediatr2004144557458015126989
   PubMed Web of Science ®Google Scholar
• HarmatzPKetteridgeDGiuglianiRMPS VI Study GroupDirect comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatasePediatrics20051156e681e68915930196
   PubMed Web of Science ®Google Scholar
• HarmatzPGiuglianiRSchwartzIMPS VI Phase 3 Study GroupEnzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyJ Pediatr2006148453353916647419
   PubMed Web of Science ®Google Scholar
• HarmatzPGiuglianiRSchwartzIVMPS VI Study GroupLong-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfataseMol Genet Metab200894446947518502162
   PubMed Web of Science ®Google Scholar
• FDA Advisory Committee Briefing Document Elosulfase alfa for Mucopolysaccharidosis Type IVA2013 Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/endocrinologicandmetabolicdrugsadvisorycommittee/ucm375126.pdfAccessed November 19, 2013
   Google Scholar
• ConnockMJuarez-GarciaAFrewEA systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry’s disease and mucopolysaccharidosis type IHealth Technol Assess2006102016
   Web of Science ®Google Scholar
• RohrbachMClarkeJTTreatment of lysosomal storage disorders: progress with enzyme replacement therapyDrugs200767182697271618062719
   PubMed Web of Science ®Google Scholar
• ChirinoAJMire-SluisACharacterizing biological products and assessing comparability following manufacturing changesNat Biotechnol200422111383139115529163
   PubMed Web of Science ®Google Scholar
• ParveenSSahooSKNanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugsClin Pharmacokinet2006451096598816984211
   PubMed Web of Science ®Google Scholar
• DicksonPPeinovichMMcEnteeMImmune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis IJ Clin Invest200811882868287618654665
   PubMed Web of Science ®Google Scholar
• TomatsuSMontañoAMDungVCEnhancement of drug delivery: enzyme replacement therapy for murine Morquio A syndromeMol Ther20101861094110220332769
   PubMed Web of Science ®Google Scholar
• RowanDJTomatsuSGrubbJHLong circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine modelMol Genet Metab20121071–216117222902520
   PubMed Web of Science ®Google Scholar
• RodríguezAEspejoAJHernándezAEnzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21J Ind Microbiol Biotechnol201037111193120120582614
   PubMed Web of Science ®Google Scholar
• RodriguezAMorenoJSánchezJMorenoJDíazDProduction of recombinant human N-acetylgalactosamine-6-sulfate sulfatase enzyme in Pichia pastorisMol Genet Metab20131082S79S80
   Web of Science ®Google Scholar
• SandsMSBarkerJEVoglerCTreatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonatesLab Invest19936866766868515654
   PubMed Web of Science ®Google Scholar
• SoperBWLessardMDVoglerCANonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiencyBlood20019751498150411222399
   PubMed Web of Science ®Google Scholar
• LauAAShamsaniNJWinnerLKNeonatal bone Marrow transplantation in MPS IIIA miceJIMD Rep2013812113223430528
   PubMedGoogle Scholar
• PatelPSuzukiYTanakaAImpact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndromeMol Genet Metab Rep2014118419625061571
   PubMedGoogle Scholar
• TanjuakioJSuzukiYPatelPActivities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantationMol Genet Metab2015114216116925468646
   PubMed Web of Science ®Google Scholar
• FujisakiJTokunagaYTakahashiTShimojoFKimuraSHataTOsteotropic drug delivery system (ODDS) based on biphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized ratsJ Drug Target1998521291389588869
   PubMed Web of Science ®Google Scholar
• SekidoTSakuraNHigashiYNovel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potentialJ Drug Target20019211112111697106
   PubMed Web of Science ®Google Scholar
• YokogawaKMiyaKSekidoTSelective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized miceEndocrinology200114231228123311181539
   PubMed Web of Science ®Google Scholar
• NishiokaTTomatsuSGutierrezMATargeted drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptideMol Genet Metab200688324425516616566
   PubMed Web of Science ®Google Scholar
• MillánJLNarisawaSLemireIEnzyme replacement therapy for murine hypophosphatasiaJ Bone Miner Res200823677778718086009
   PubMed Web of Science ®Google Scholar
• WhyteMPGreenbergCRSalmanNJEnzyme-replacement therapy in life-threatening hypophosphatasiaN Engl J Med201281090491322397652
   PubMedGoogle Scholar
• OikawaHTomatsuSHauptBMontañoAMShimadaTSlyWSEnzyme replacement therapy on hypophosphatasia mouse modelJ Inherit Metab Dis201437230931723978959
   PubMed Web of Science ®Google Scholar
• MontañoAMOikawaHTomatsuSAcidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII miceMol Genet Metab200894217818918359257
   PubMed Web of Science ®Google Scholar
• ClearyMAWraithJEThe presenting features of mucopolysaccharidosis type IH (Hurler syndrome)Acta Paediatr19958433373397780260
   PubMed Web of Science ®Google Scholar
• ChakrapaniAClearyMAWraithJEDetection of inborn errors of metabolism in the newbornArch Dis Child Fetal Neonatal Ed2001843F205F21011320051
   PubMed Web of Science ®Google Scholar
• PaciottiSPersichettiEPagliardiniSFirst pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA geneClin Chim Acta201241323–241827183122820396
   PubMed Web of Science ®Google Scholar
• ScottCRElliottSBurokerNIdentification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometryJ Pediatr2013163249850323465405
   PubMed Web of Science ®Google Scholar
• LinSPLinHYWangTJA pilot newborn screening program for Mucopolysaccharidosis type I in TaiwanOrphanet J Rare Dis201381823286897
   PubMed Web of Science ®Google Scholar
• TomatsuSFujiiTFukushiMNewborn screening and diagnosis of mucopolysaccharidosesMol Genet Metab20131101–2425323860310
   PubMed Web of Science ®Google Scholar
• BeckMBraunSCoerdtWMerzEYoungESewellACFetal presentation of Morquio disease type APrenat Diagn19921212101910291287637
   PubMed Web of Science ®Google Scholar
• OhashiAMontañoAMColónJEOgumaTLuisiriATomatsuSSacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA diseaseActa Paediatr200998576876919389117
   PubMed Web of Science ®Google Scholar
• TomatsuSOriiKOVoglerCMouse model of N- acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A diseaseHum Mol Genet200312243349335814583446
   PubMed Web of Science ®Google Scholar
• TomatsuSAlméciga-DíazCJMontañoAMTherapies for the bone in mucopolysaccharidosesMol Genet Metab201511429410925537451
   PubMed Web of Science ®Google Scholar
• BilezikianJPRaiszLGMartinJPrinciples of Bone BiologySan Diego, CAAcademic Press2008
   Google Scholar
• WraithJEScarpaMBeckMMucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyEur J Pediatr2008167326727718038146
   PubMed Web of Science ®Google Scholar
• HendrikszCVellodiAJonesSLong term outcomes of a phase1/2, multicenter, open-label, dose-escalation study to evaluate the safety, tolerability, and efficacy of BMN 110 in patients with mucopolysaccharidosis IVA (Morquio A syndrome)Mol Genet Metab20121052S35
   Web of Science ®Google Scholar
• HendrikszCJGiuglianiRHarmatzPSTRIVE InvestigatorsMulti-domain impact of elosulfase alfa in Morquio A syndrome in the pivotal phase III trialMol Genet Metab2015114217818525284089
   PubMed Web of Science ®Google Scholar
• ShahMRHasselbladVGheorghiadeMPrognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathyAm J Cardiol200188998799311703994
   PubMed Web of Science ®Google Scholar
• StokowskiLAPariserAMulbergAFDA’s rare disease program:a rare opportunity to help kidsMedscape2014 Available from: http://www.medscape.com/viewarticle/821918_2Accessed: March 18, 2014
   Google Scholar
• BrooksMFDA clears the first drug for rare Morquio A SyndromeMedscape2014 Available from: http://www.medscape.com/viewarticle/820677Accessed: February 14, 2014
   Google Scholar
• TomatsuSMontañoAMOhashiAEnzyme replacement therapy in a murine model of Morquio A syndromeHum Mol Genet200817681582418056156
   PubMed Web of Science ®Google Scholar
• TomatsuSMontañoAMOikawaHEnzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?Mol Genet Metab2015114219520224953405
   PubMed Web of Science ®Google Scholar
• OldbergAFranzenAHeinegardDThe primary structure of a cell-binding bone sialoproteinJ Biol Chem19882633619430194323198635
   PubMed Web of Science ®Google Scholar
• KasugaiSFujisawaRWakiYMiyamotoKOhyaKSelective drug delivery system to bone: small peptide (Asp)6 conjugationJ Bone Miner Res200015593694310804024
   PubMed Web of Science ®Google Scholar
• NagataTBellowsCGKasugaiSButlerWTSodekJBiosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin) in association with mineralized-tissue formation by fetal-rat calvarial cells in cultureBiochem J1991274pt25135202006915
   PubMedGoogle Scholar
• ButlerWTThe nature and significance of osteopontinConnect Tissue Res1989232–31231362698313
   PubMed Web of Science ®Google Scholar
• DesnickRJSchuchmanEHEnzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challengesAnnu Rev Genomics Hum Genet20121330733522970722
   PubMed Web of Science ®Google Scholar
• GrabowskiGAGolemboMShaaltielYTaliglucerase alfa: an enzyme replacement therapy using plant cell expression technologyMol Genet Metab201411211824630271
   PubMed Web of Science ®Google Scholar
• TielsPBaranovaEPiensKA bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymesBiotechnology2012301212251231
   Google Scholar
• WendelerMLemmTWeisgerberJExpression of recombinant human GM2-activator protein in insect cells: purification and characterization by mass spectrometryProtein Expr Purif200327225926612597885
   PubMed Web of Science ®Google Scholar
• Poutou-PiñalesRAVanegas NiñoALandázuriPHuman sulfatase transiently and functionally active expressed in E. coli K12Electron J Biotechnol20101356
   Web of Science ®Google Scholar
• Morales-ÁlvarezEDRivera-HoyosCMBaena-MoncadaAMLaboratory scale production of the human recombinant iduronate 2-sulfate sulfatase-Like from Pichia pastorisAfr J Biotechnol2009817861792
   Google Scholar
• Espejo-MojicaAMosqueraARDíazSARodríguezEAAlméciga-DíazCJBarreraLAProduction of human recombinant alpha- N-acetylglucosaminidase enzymes in two Pichia pastoris strainsMol Genet Metab20131082S38S39
   Web of Science ®Google Scholar
• DemainALVaishnavPProduction of recombinant proteins by microbes and higher organismsBiotechnol Adv200927329730619500547
   PubMed Web of Science ®Google Scholar
• TomatsuSMontañoAMGutierrezMCharacterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfataseMol Genet Metab2007911697817336563
   PubMed Web of Science ®Google Scholar
• Dvorak-EwellMWendtDHagueCEnzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type micePLoS One201058e1219420808938
   PubMed Web of Science ®Google Scholar
• HernándezAVelásquezOLeonardiFEffect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21J Microbiol Biotechnol201323568969823648860
   PubMed Web of Science ®Google Scholar
• RodríguezAEspejoAJHernándezACharacterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A diseaseProcess Biochem2012471220972102
   Web of Science ®Google Scholar
• AlmecigaCJRodríguez-LópezASánchezJProduction of an active recombinant human N-acetylgalactosamine-6-sulfate sulfatase enzyme in Pichia pastorisMol Genet Metab20141112S19
   Web of Science ®Google Scholar
• LandgrebeJDierksTSchamidtBvon FiguraKThe human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotesGene2003316475614563551
   PubMed Web of Science ®Google Scholar
• ToveyMGLallemandCImmunogenicity and other problems associated with the use of biopharmaceuticalsTher Adv Drug Saf20112311312825083207
   PubMedGoogle Scholar
• DuHSchiaviSLevineMMishraJHeurMGrabowskiGAEnzyme therapy for lysosomal acid lipase deficiency in the mouseHum Mol Genet200110161639164811487567
   PubMed Web of Science ®Google Scholar
• WangCHwuWLinKLong-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantationWorld J Pediatr20084215215418661775
   PubMed Web of Science ®Google Scholar
• BoelensJTrends in haematopoietic cell transplantation for inborn errors of metabolismJ Inherit Metab Dis2006292–341342016763911
   PubMed Web of Science ®Google Scholar
• OrchardPBlazarBWagnerJCharnasLKrivitWTolarJHematopoietic cell therapy for metabolic diseaseJ Pediatr2007151434034617889065
   PubMed Web of Science ®Google Scholar
• RovelliAMThe controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an updateBone Marrow Transplant200841suppl 2S87S8918545253
   PubMed Web of Science ®Google Scholar
• VellodiAYoungECooperALidchiVWinchesterBWraithJELong-term follow-up following bone marrow transplantation for Hunter diseaseJ Inherit Metab Dis199922563864810399096
   PubMed Web of Science ®Google Scholar
• TolarJGrewalSSBjorakerKJCombination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndromeBone Marrow Transplant200841653153518037941
   PubMed Web of Science ®Google Scholar
• TanakaAOkuyamaTSuzukiYLong-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in JapanMol Genet Metab2012107351352023022072
   PubMed Web of Science ®Google Scholar
• TomatsuSYasudaEPatelPMorquio A syndrome: diagnosis and current and future therapiesPediatr Endocrinol Rev201412suppl 114115125345096
   PubMed Web of Science ®Google Scholar
• YamadaYKatoKSukegawaKTreatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutationBone Marrow Transplant19982166296349543069
   PubMed Web of Science ®Google Scholar
• KhannaGVan HeestAEAgelJAnalysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantationBone Marrow Transplant200739633133417277793
   PubMed Web of Science ®Google Scholar
• HobbsJRHugh-JonesKBarrettAJReversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantationLancet1981282497097126116856
   PubMed Web of Science ®Google Scholar
• GuffonNSouilletGMaireIStraczekJGuibaudPFollow-up of nine patients with Hurler syndrome after bone marrow transplantationJ Pediatr199813311191259672523
   PubMed Web of Science ®Google Scholar
• VellodiAYoungEPCooperABone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArch Dis Child199776292999068295
   PubMed Web of Science ®Google Scholar
• StabaSLEscolarMLPoeMCord-blood transplants from unrelated donors in patients with Hurler’s syndromeN Engl J Med2004350191960196915128896
   PubMed Web of Science ®Google Scholar
• KrivitWPierpontMEAyazKBone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantationN Engl J Med198431125160616116150438
   PubMed Web of Science ®Google Scholar
• BoelensJJAldenhovenMPurtillDInborn Errors Working Party of European Blood and Marrow Transplant groupDuke University Blood and Marrow Transplantation ProgramCentre for International Blood and Marrow ResearchOutcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioningBlood20131213981398723493783
   PubMed Web of Science ®Google Scholar
• HerskhovitzEYoungERainerJBone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-upJ Inherit Metab Dis199922506210070618
   PubMed Web of Science ®Google Scholar
• MalatackJConsoliniDBayeverEThe status of hematopoietic stem cell transplantation in lysosomal storage diseasePediatr Neurol20032939140314684234
   PubMed Web of Science ®Google Scholar
• BeckMNew therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapyHum Genet200712112217089160
   PubMed Web of Science ®Google Scholar
• TurbevilleSNicelyHRizzoJDClinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VIMol Genet Metab201110211111520980181
   PubMed Web of Science ®Google Scholar
• GuffonNBertrandYForestIFouilhouxAFroissartRBone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 yearsJ Pediatr200915473373719167723
   PubMed Web of Science ®Google Scholar
• ArayaKSakaiNMohriILocalized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantationMol Genet Metab20099825526319556155
   PubMed Web of Science ®Google Scholar
• FieldREBuchananJACopplemansMGAichrothPMBone-marrow transplantation in hurler’s syndrome: effect on skeletal developmentJ Bone Joint Surg Br19947669759817983131
   PubMedGoogle Scholar
• StoopFJKruytMCvan der LindenMHSakkersRJvan HasseltPMCasteleinRMPrevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantationJIMD Rep20139172923430544
   PubMedGoogle Scholar
• VellodiAYoungEPCooperABone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArch Dis Child199776292999068295
   PubMed Web of Science ®Google Scholar
• SouilletGGuffonNMaireIOutcome of 27 patients with hurler’s syndrome transplanted from either related or unrelated haematopoietic stem cell sourcesBone Marrow Transplant200331121105111712796790
   PubMed Web of Science ®Google Scholar
• MastersonELMurphyPGO’MearaAMooreDPDowlingFEFogartyEEHip dysplasia in hurler’s syndrome: orthopaedic management after bone marrow transplantationJ Pediatr Orthop19961667317338906643
   PubMed Web of Science ®Google Scholar
• TaylorCBradyPO’MearaAMooreDDowlingFFogartyEMobility in Hurler syndromeJ Pediatr Orthop200828216316818388709
   PubMed Web of Science ®Google Scholar
• WeissteinJSDelgadoESteinbachLSHartKPackmanSMusculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantationJ Pediatr Orthop20042419710114676543
   PubMed Web of Science ®Google Scholar
• AldenhovenMSakkersRJBoelensJde KoningTJWulffraatNMMusculoskeletal manifestations of lysosomal storage disordersAnn Rheum Dis200968111659166519822711
   PubMed Web of Science ®Google Scholar
• LangereisEJBorgoACrushellETreatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedureOrphanet J Rare Dis201381923286897
   PubMed Web of Science ®Google Scholar
• PrasadVKKurtzbergJTransplant outcomes in mucopolysaccharidosesSemin Hematol2010471596920109613
   PubMed Web of Science ®Google Scholar
• MitchellRNivison-SmithIAnazodoAOutcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient RegistryPediatr Transplant201317658258823802616
   PubMed Web of Science ®Google Scholar
• ChinenYHigaTTomatsuSSuzukiYOriiTHyakunaNLong-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVAMol Genet Metab Rep20141314125593792
   PubMedGoogle Scholar
• PievaniAAzarioIAntoliniLNeonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type IBlood Epub2014108
   Web of Science ®Google Scholar
• AronsonJKBiomarkers and surrogate endpointsBr J Clin Pharmacol200559549149415842546
   PubMed Web of Science ®Google Scholar
• AronsonJKResearch priorities in biomarkers and surrogate end-pointsBr J Clin Pharmacol201273690090722360291
   PubMed Web of Science ®Google Scholar
• TomatsuSOkamuraKTaketaniTDevelopment and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVAPediatr Res200455459259714711889
   PubMed Web of Science ®Google Scholar
• OgumaTTomatsuSOkazakiOAnalytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometryBiomed Chromatogr200721435636217236248
   PubMed Web of Science ®Google Scholar
• TomatsuSMontañoAMOgumaTValidation of keratan sulfate level in mucopolysaccharidosis IVA by liquid tandem mass spectrometry methodJ Inherit Metab Dis201033suppl 3S35S4220107903
   PubMedGoogle Scholar
• HintzeJPTomatsuSFujiiTComparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urineBiomark Insights20116697821792275
   PubMedGoogle Scholar
• MartellLACunicoRLOhhJFulkersonWFurneauxRFoehrEDValidation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndromeBioanalysis20113161855186621877895
   PubMed Web of Science ®Google Scholar
• DũngVCTomatsuSMontañoAMMucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levelsMol Genet Metab20131101–212913823876334
   PubMed Web of Science ®Google Scholar
• ShimadaTTomatsuSMasonRWDi-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis IVAJ Inherit Metab Dis Reports2014
   Google Scholar
• HarmatzPMengelKEGiuglianiRThe Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjectsMol Genet Metab20131091546123452954
   PubMed Web of Science ®Google Scholar